Most Recent
London City Equities has reached a settlement with listed firm Excelsior in a case alleging shareholder oppression over a decision to sell off a subsidiary for $101 million and not distribute the proceeds.
Keybridge Capital has filed a lawsuit against E&P Investments seeking $1.7 million in compensation over the allegedly unfair conversion of almost 40,000 URFPA units held in E&P’s New York real estate investment fund as part of a share buyback program.
ASIC has filed proceedings against mineral exploration company AVZ Minerals and two of its directors, alleging the company failed to disclose a critical legal dispute, including a forgery claim, relating to a $32 million lithium mine deal.
A judge has ordered a flat contingency fee at a rate below the maximum sought by the firm running a class action against Mineral Resources, agreeing with a colleague that recent shareholder class action losses don't justify a higher percentage.
A judge has questioned the tiered structure of a group costs order sought by the law firm running a class action against Mineral Resources, but the firm argued Wednesday it would need the highest rate if a flat fee were ordered.
The funder and law firms that ran a shareholder class action against BHP over the collapse of the company's Samarco Fundão dam in Brazil will seek approval for deductions that will see half of the $110 million settlement go to group members.
iSignthis and auditor Grant Thornton have each pointed the finger at each other in response to a shareholder class action over the delisted fintech's 2018 financial statements.
The firm wants a bigger slice of any recovery in its case against Paladin Energy, but its clearer funding arrangement and realistic litigation budget give it the edge over a rival class action outfit, a judge has found.
A contest to run a class action against Paladin Energy played out Monday, with two law firms each positioning themselves as the better bet, one for their funding and resources, the other for their contingency fee rate.
Mayne Pharma has won a dispute with US drug maker Cosette over the termination of a $672 million merger agreement, with a judge finding Mayne did not breach its continuous disclosure obligations by failing to disclose a letter from the US FDA sooner.